OptimizeRx Q3 revenue up 53% to $16.1M; GAAP net income $0.04M

OptimizeRx Corp

2021-Q3 EPS reported -$0.01 revenue$40,979,801

Revenue $16.1M (+53% YoY); brands on platform increased to 182 from 140.
GAAP net income $0.04M ($0.00 EPS) vs loss of $0.3M YoY; non-GAAP net income $1.6M ($0.09 EPS).
Gross margin 56.3% (slight decrease from 57.2%); cash $85M.
RWE solution gaining traction; average client ROI 13:1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.